BioMarin Pharmaceuticals
BMRN
BMRN
306 hedge funds and large institutions have $9.95B invested in BioMarin Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 101 increasing their positions, 115 reducing their positions, and 39 closing their positions.
Holders
306
Holders Change
+12
Holders Change %
+4.08%
% of All Funds
8.89%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.2%
New
51
Increased
101
Reduced
115
Closed
39
Calls
$94.9M
Puts
$58.2M
Net Calls
+$36.7M
Net Calls Change
+$3.33M
Top Buyers
1 |
1
Wells Fargo
San Francisco,
California
|
$272M |
2 |
BBA
2
Baker Bros. Advisors
New York
|
$137M |
3 |
3
Alkeon Capital Management
New York
|
$70.5M |
4 |
4
Millennium Management
New York
|
$66.7M |
5 |
5
State Street
Boston,
Massachusetts
|
$224M |